Abstract
Pentoxifylline (PTX), a phosphodiesterase inhibitor, is known to downregulate tumor necrosis factor-alpha (TNF-α) secretion induced by lipopolysacchride (LPS) and gamma interferon (IFN-γ). We have had limited success in treating leprosy reactions, including erythema nodosum leprosum (ENL), in which TNF-α has been identified as a major proinflammatory cytokine. PTX inhibited production of NO (IC50 ≅ 1.0 mg/ml) and TNF-α (IC50 ≅ 0.05 mg/ml) in a dose-dependent fashion. As little as 0.5 mg/ml of PTX decreased NO production and 0.01 mg/ml of PTX inhibited TNF-α production. Western blot analyses demonstrated that iNOS was suppressed by PTX. Northern blot analyses showed significant reduction of TNF-α mRNA. We conclude that PTX is an effective inhibitor of lipoarabinomannan (LAM)-induced TNF-α production at both the product and transcriptional levels in our macrophage cell line. PTX also showed moderate inhibition of NO at the product level as well as translation of iNOS.
| Original language | English |
|---|---|
| Pages (from-to) | 225-233 |
| Number of pages | 9 |
| Journal | International Journal of Leprosy and Other Mycobacterial Diseases |
| Volume | 69 |
| Issue number | 3 |
| State | Published - 2001 |
Fingerprint
Dive into the research topics of 'Pentoxifylline downregulates nitric oxide and tumor necrosis factor-α induced by mycobacterial lipoarabinomannan in a macrophage cell line'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver